Shinsegae Inte (031430)
Korea Stock Exchange · Korea · prices in KRW · close of 19 Oct 2026
Key indicators
| Last close | KRW 11,460.00 |
|---|---|
| 52-week range | 9,242.18 – 17,130.00 |
| Return, 1 month / 3 months | +9.0% / −4.3% |
| Return, 1 year / 3 years | +16.0% / −32.4% |
| Trend | Below its 200-day average |
| RSI (14) | 64 |
| Volatility (1 year) | 48.1% |
| Worst drawdown (1 year) | -39.7% |
| Average daily value traded | 905.61M KRW |
| Dividend yield | 3.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Shinsegae International is a South Korean fashion and beauty company based in Seoul. It imports and distributes foreign luxury and contemporary clothing brands in the domestic market, and it develops its own fashion labels. The company also runs a cosmetics business, offering its own beauty lines and distributing imported fragrance and skincare brands. Its customers are mainly department stores, specialty retailers and online shoppers in Korea who buy designer apparel, accessories and cosmetics.
The shares are listed on the Korea Stock Exchange in Korea under the code 031430, and the price on this page is in South Korean won (KRW). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Shinsegae Inte (031430) trades on the Korea Stock Exchange in Korea. It last closed at KRW 11,460.00 on 19 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 398 of 934 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 16.0% and over the last three months it fell 4.3%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Korea Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 53 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -5.0% | ||
| From 52-week high | -32.2% | ||
| Momentum | 53 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -4.3% | ||
| 6-month return | -8.6% | ||
| 12-month return, skipping the last month | 6.4% | ||
| Risk (lower is better) | 57 · Fair | Typical risk for this exchange. | |
| Volatility (1 year) | 48.1% | ||
| Worst drawdown (1 year) | -39.7% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 905.61M KRW | ||
| Zero-volume days | 0.0% | ||
| Income | 53 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.5% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | +4.8% |
|---|---|
| 1 month | +9.0% |
| 3 months | −4.3% |
| 6 months | −8.6% |
| 1 year | +16.0% |
| 3 years | −32.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 10,664.60 / 12,065.85 |
|---|---|
| Golden / death cross (60 days) | Death, 35 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 394.04 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 30 Mar 2026 | KRW 400.0000 |
| 28 Mar 2025 | KRW 400.0000 |
| 27 Dec 2023 | KRW 400.0000 |
| 28 Dec 2022 | KRW 500.0000 |
| 29 Dec 2021 | KRW 1,500.0000 |
| 29 Dec 2020 | KRW 1,100.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Korea Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.